64 related articles for article (PubMed ID: 1581002)
1. The structural basis of the poor fibrin specificity of urokinase(I)--knowledge-based prediction of kringle structures of urokinase and its related proteins.
Liu JN; Lu L; Gao X; Wang J; Zhu DX; Lai LH; Xu XJ; Tang YQ
Sci China B; 1992 Feb; 35(2):176-82. PubMed ID: 1581002
[TBL] [Abstract][Full Text] [Related]
2. Lysine/fibrin binding sites of kringles modeled after the structure of kringle 1 of prothrombin.
Tulinsky A; Park CH; Mao B; Llinás M
Proteins; 1988; 3(2):85-96. PubMed ID: 3135547
[TBL] [Abstract][Full Text] [Related]
3. The construction and expression of chimeric urokinase-type plasminogen activator genes containing kringle domains of human plasminogen.
Boutaud A; Castellino FJ
Arch Biochem Biophys; 1993 Jun; 303(2):222-30. PubMed ID: 8512311
[TBL] [Abstract][Full Text] [Related]
4. Solution structure of the kringle domain from urokinase-type plasminogen activator.
Li X; Bokman AM; Llinás M; Smith RA; Dobson CM
J Mol Biol; 1994 Feb; 235(5):1548-59. PubMed ID: 8107091
[TBL] [Abstract][Full Text] [Related]
5. The genetic relationships between the kringle domains of human plasminogen, prothrombin, tissue plasminogen activator, urokinase, and coagulation factor XII.
Castellino FJ; Beals JM
J Mol Evol; 1987; 26(4):358-69. PubMed ID: 3131537
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein(a): structure-function relationship at the lysine-binding site and plasminogen activator cleavage site.
Anglés-Cano E; Rojas G
Biol Chem; 2002 Jan; 383(1):93-9. PubMed ID: 11928826
[TBL] [Abstract][Full Text] [Related]
7. Characterization of domain deletion and/or duplication mutants of a recombinant chimera of tissue-type plasminogen activator and urokinase-type plasminogen activator (rt-PA/u-PA).
Nelles L; Lijnen HR; Van Nuffelen A; Demarsin E; Collen D
Thromb Haemost; 1990 Aug; 64(1):53-60. PubMed ID: 2148847
[TBL] [Abstract][Full Text] [Related]
8. Structure of the lysine-fibrin binding subsite of human plasminogen kringle 4.
Mulichak AM; Tulinsky A
Blood Coagul Fibrinolysis; 1990 Dec; 1(6):673-9. PubMed ID: 1966798
[TBL] [Abstract][Full Text] [Related]
9. Crystal structures of apolipoprotein(a) kringle IV37 free and complexed with 6-aminohexanoic acid and with p-aminomethylbenzoic acid: existence of novel and expected binding modes.
Mikol V; LoGrasso PV; Boettcher BR
J Mol Biol; 1996 Mar; 256(4):751-61. PubMed ID: 8642595
[TBL] [Abstract][Full Text] [Related]
10. Recombinant kringle IV-10 modules of human apolipoprotein(a): structure, ligand binding modes, and biological relevance.
Mochalkin I; Cheng B; Klezovitch O; Scanu AM; Tulinsky A
Biochemistry; 1999 Feb; 38(7):1990-8. PubMed ID: 10026282
[TBL] [Abstract][Full Text] [Related]
11. Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site.
Colucci M; Cavallo LG; Agnelli G; Mele A; Bürgi R; Heim J; Semeraro N
Thromb Haemost; 1993 May; 69(5):466-72. PubMed ID: 8391727
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and expression of a gene from kringle-2 domain of tissue plasminogen activator in E. coli.
Hua ZC; Fu HL; Chen YH; Yu RR; Wang J; Zhu DX
Sci China B; 1994 Jun; 37(6):667-76. PubMed ID: 7917003
[TBL] [Abstract][Full Text] [Related]
13. The 2.3 A crystal structure of the catalytic domain of recombinant two-chain human tissue-type plasminogen activator.
Lamba D; Bauer M; Huber R; Fischer S; Rudolph R; Kohnert U; Bode W
J Mol Biol; 1996 Apr; 258(1):117-35. PubMed ID: 8613982
[TBL] [Abstract][Full Text] [Related]
14. The structure basis of the poor fibrin specificity of urokinase (II)--The inhibition of urokinase A chain 149-157 on the fibrin stimulated activation of plasminogen by tissue type plasminogen activator.
Song A; Liu JN; Yu RR; Cui DF; Zhou TM; Cui HR; Zhu DX
Sci China B; 1992 Aug; 35(8):966-73. PubMed ID: 1338753
[TBL] [Abstract][Full Text] [Related]
15. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
[TBL] [Abstract][Full Text] [Related]
16. Role of tryptophan-63 of the kringle 2 domain of tissue-type plasminogen activator in its thermal stability, folding, and ligand binding properties.
Chang Y; Zajicek J; Castellino FJ
Biochemistry; 1997 Jun; 36(25):7652-63. PubMed ID: 9201906
[TBL] [Abstract][Full Text] [Related]
17. Structure and binding determinants of the recombinant kringle-2 domain of human plasminogen to an internal peptide from a group A Streptococcal surface protein.
Rios-Steiner JL; Schenone M; Mochalkin I; Tulinsky A; Castellino FJ
J Mol Biol; 2001 May; 308(4):705-19. PubMed ID: 11350170
[TBL] [Abstract][Full Text] [Related]
18. Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP).
Donate LE; Gherardi E; Srinivasan N; Sowdhamini R; Aparicio S; Blundell TL
Protein Sci; 1994 Dec; 3(12):2378-94. PubMed ID: 7756992
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis of specific inhibition of urokinase plasminogen activator by amiloride.
Jankun J; Skrzypczak-Jankun E
Cancer Biochem Biophys; 1999 Jul; 17(1-2):109-23. PubMed ID: 10738907
[TBL] [Abstract][Full Text] [Related]
20. Structure and function of human tissue-type plasminogen activator (t-PA).
van Zonneveld AJ; Veerman H; MacDonald ME; van Mourik JA; Pannekoek H
J Cell Biochem; 1986; 32(3):169-78. PubMed ID: 3097031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
